Family · Pharmaceutical analytical standards
Modafinil
A wakefulness-promoting drug, developed in France in the 1970s and approved in 1994 in France and in 1998 in the United States, mainly for the excessive sleepiness of narcolepsy. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.
Did you know?It is the main metabolite of adrafinil, an older compound from the same chemical series; French neurophysiologist Michel Jouvet, a leading sleep researcher, contributed to its development.
No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
